| Glycoprotein non-metastatic melanoma protein B (GPNMB): An attractive target in atherosclerosis. | Glycoprotein non-metastatic melanoma protein B (GPNMB): An attractive target in atherosclerosis.
Yu X, Li M, Wang C, Guan X. | 09/9/2024 |
| The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-beta signaling. | The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-β signaling.
Vakayil M, Madani AY, Agha MV, Majeed Y, Hayat S, Yonuskunju S, Mohamoud YA, Malek J, Suhre K, Mazloum NA., Free PMC Article | 06/12/2024 |
| Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis. | Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis.
Gibbons E, Taya M, Wu H, Lopa SH, Moss J, Henske EP, McCormack FX, Hammes SR., Free PMC Article | 06/11/2024 |
| Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif. | Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif.
Kimura T, Okita Y, Nagumo Y, Chin JM, Fikry MA, Shiga M, Kandori S, Kawahara T, Suzuki H, Nishiyama H, Kato M. | 06/5/2024 |
| Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma. | Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F, Haneke H, Efe IE, Kuhrt LD, Motta E, Nickl B, Flüh C, Synowitz M, Dzaye O, Bader M, Kettenmann H., Free PMC Article | 04/5/2024 |
| The association between plasma GPNMB and Parkinson's disease and multiple system atrophy. | The association between plasma GPNMB and Parkinson's disease and multiple system atrophy.
Li K, Wang P, Li W, Yan JH, Ge YL, Zhang JR, Wang F, Mao CJ, Liu CF. | 02/27/2024 |
| HOMER3 promotes liver hepatocellular carcinoma cancer progression by -upregulating EZH2 and mediating miR-361/GPNMB axis. | HOMER3 promotes liver hepatocellular carcinoma cancer progression by -upregulating EZH2 and mediating miR-361/GPNMB axis.
Chen L, Shan X, Wan X, Zha W, Fan R. | 02/15/2024 |
| Gpnmb silencing protects against hyperoxia-induced acute lung injury by inhibition of mitochondrial-mediated apoptosis. | Gpnmb silencing protects against hyperoxia-induced acute lung injury by inhibition of mitochondrial-mediated apoptosis.
Wang X, Qin S, Ren Y, Feng B, Liu J, Yu K, Yu H, Liao Z, Mei H, Tan M. | 01/4/2024 |
| Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity. | Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity.
Bianco V, Kratky D., Free PMC Article | 12/16/2023 |
| Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression. | Prognostic evaluation of oral squamous cell carcinoma based on pleiotrophin, urokinase plasminogen activator, and glycoprotein nonmetastatic melanoma protein B expression.
Ma Y, Liu Y, Meng H., Free PMC Article | 11/18/2023 |
| miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1alpha/HK2 axis. | miR-532-3p suppresses proliferation and invasion of ovarian cancer cells via GPNMB/HIF-1α/HK2 axis.
Tuo X, Zhou Y, Yang X, Ma S, Liu D, Zhang X, Hou H, Wang R, Li X, Zhao L. | 10/29/2022 |
| GPNMB: a potent inducer of immunosuppression in cancer. | GPNMB: a potent inducer of immunosuppression in cancer.
Lazaratos AM, Annis MG, Siegel PM. | 10/15/2022 |
| GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis. | GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma-Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis.
Kawasaki Y, Suzuki H, Suzuki S, Yamada T, Suzuki M, Ito A, Hatakeyama H, Miura M, Omori Y., Free PMC Article | 09/17/2022 |
| GPNMB confers risk for Parkinson's disease through interaction with alpha-synuclein. | GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
Diaz-Ortiz ME, Seo Y, Posavi M, Carceles Cordon M, Clark E, Jain N, Charan R, Gallagher MD, Unger TL, Amari N, Skrinak RT, Davila-Rivera R, Brody EM, Han N, Zack R, Van Deerlin VM, Tropea TF, Luk KC, Lee EB, Weintraub D, Chen-Plotkin AS., Free PMC Article | 09/3/2022 |
| Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy. | Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy.
Taghizadeh LA, King CJ, Nascene DR, Gupta AO, Orchard PJ, Higgins L, Markowski TW, Nolan EE, Furcich JW, Lund TC., Free PMC Article | 05/28/2022 |
| GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms. | GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
Salles DC, Asrani K, Woo J, Vidotto T, Liu HB, Vidal I, Matoso A, Netto GJ, Argani P, Lotan TL., Free PMC Article | 05/7/2022 |
| GPNMB plays an active role in the M1/M2 balance. | GPNMB plays an active role in the M1/M2 balance.
Zhang H, Zhang S, Dang X, Lin L, Ren L, Song R. | 03/26/2022 |
| Two missense mutations in GPNMB cause autosomal recessive amyloidosis cutis dyschromica in the consanguineous pakistani families. | Two missense mutations in GPNMB cause autosomal recessive amyloidosis cutis dyschromica in the consanguineous pakistani families.
Rahman OU, Kim J, Mahon C, Jelani M, Kang C. | 03/19/2022 |
| Genetic ablation of Gpnmb does not alter synuclein-related pathology. | Genetic ablation of Gpnmb does not alter synuclein-related pathology.
Brendza R, Lin H, Stark K, Foreman O, Tao J, Pierce A, Ngu H, Shen K, Easton AE, Bhangale T, Chang D, Bingol B, Friedman BA. | 03/5/2022 |
| Amyloidosis cutis dyschromica cases caused by GPNMB mutations with different inheritance patterns. | Amyloidosis cutis dyschromica cases caused by GPNMB mutations with different inheritance patterns.
Qin W, Wang H, Zhong W, Bai J, Qiao J, Lin Z. | 02/19/2022 |
| Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity. | Association Between Factors Involved in Bone Remodeling (Osteoactivin and OPG) With Plasma Levels of Irisin and Meteorin-Like Protein in People With T2D and Obesity.
Cherian P, Al-Khairi I, Jamal M, Al-Sabah S, Ali H, Dsouza C, Alshawaf E, Al-Ali W, Al-Khaledi G, Al-Mulla F, Abu-Farha M, Abubaker J., Free PMC Article | 02/12/2022 |
| Mapping the serum proteome to neurological diseases using whole genome sequencing. | Mapping the serum proteome to neurological diseases using whole genome sequencing.
Png G, Barysenka A, Repetto L, Navarro P, Shen X, Pietzner M, Wheeler E, Wareham NJ, Langenberg C, Tsafantakis E, Karaleftheri M, Dedoussis G, Mälarstig A, Wilson JF, Gilly A, Zeggini E., Free PMC Article | 01/8/2022 |
| The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33. | The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33.
Liguori M, Digifico E, Vacchini A, Avigni R, Colombo FS, Borroni EM, Farina FM, Milanesi S, Castagna A, Mannarino L, Craparotta I, Marchini S, Erba E, Panini N, Tamborini M, Rimoldi V, Allavena P, Belgiovine C., Free PMC Article | 01/1/2022 |
| Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. | Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer.
Huang YH, Chu PY, Chen JL, Huang CT, Huang CC, Tsai YF, Wang YL, Lien PJ, Tseng LM, Liu CY., Free PMC Article | 11/6/2021 |
| Elevated Circulating Levels of Glycoprotein Non-Metastatic Melanoma Protein B as a Predictor of Gestational Diabetes Mellitus. | Elevated Circulating Levels of Glycoprotein Non-Metastatic Melanoma Protein B as a Predictor of Gestational Diabetes Mellitus.
Cao C, Wei L, Han Y, Wang Y, Zhang J, Zhang L, Kang Z, Zhang J. | 09/25/2021 |